Hsu et al. reported that Snail, one of the endothelial-mesenchymal transition (EMT) markers, regulated the expression of ERCC1, and coexpression of Snail and ERCC1 predicted the poor prognosis of cisplatin-based chemotherapy for head and neck cancer [49]. Here, SNAI1 is linked to head and neck cancer.